Price Alert

Portage Biotech Inc. (PRTG)

NASDAQ: PRTG · Real-Time Price · USD

8.55

-0.25 (-2.84%)

At close: Aug 15, 2025, 3:59 PM

8.57

0.23%

After-hours: Aug 15, 2025, 07:52 PM EDT

Portage Biotech Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Cash & Equivalents	1.76M	3.33M	5.03M	5.34M	3.44M	7.7M	10.54M	13.1M	15.04M	21.18M	23.35M	25.6M	27.26M	28.62M	2.77M	3.64M	4.43M	8.2M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	146K
Long-Term Investments	n/a	n/a	n/a	6M	3.28M	4.61M	2.89M	4.77M	8.97M	9.02M	9.08M	8.78M	9.04M	9.1M	9.14M	9.9M	10.03M	10.07M
Other Long-Term Assets	n/a	14K	49K	499K	49K	51K	877K	933K	939K	36K	36K	38K	38K	58K	58K	70K	70K	34K
Receivables	570K	23K	39K	56K	481K	699K	682K	826K	838K	253K	209K	324K	749K	883K	683K	556K	451K	562K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	77K	63K	64K	n/a	n/a	115K	119K	119K	142K	142K	142K	142K	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	2.69M	5.2M	7.7M	7.52M	6.27M	10.89M	13.68M	15.53M	17.17M	23.11M	24.83M	26.27M	28.64M	30.61M	4.95M	4.2M	4.91M	8.91M
Property-Plant & Equipment	20K	27K	35K	263K	278K	293K	-2.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	34.76M	81.68M	81.68M	81.68M	189.45M	189.45M	160.71M	160.71M	160.71M	160.71M	160.71M	160.71M	160.71M	160.71M	160.71M
Total Long-Term Assets	20K	41K	84K	43.07M	86.13M	87.48M	85.45M	195.15M	199.35M	169.77M	169.83M	169.53M	169.79M	169.87M	169.91M	170.69M	170.81M	170.82M
Total Assets	2.71M	5.24M	7.78M	50.58M	92.4M	98.37M	99.13M	210.68M	216.53M	192.88M	194.66M	195.81M	198.44M	200.48M	174.86M	174.89M	175.72M	179.73M
Account Payables	49K	1.48M	482K	2.26M	2.69M	2.19M	274K	2.42M	1.43M	1.94M	188K	477K	809K	1.6M	113K	254K	343K	1.32M
Deferred Revenue	n/a	n/a	n/a	-2.26K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	40K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	150K	150K	300K	300K	300K
Other Current Liabilities	n/a	535K	-37K	2.26K	n/a	n/a	n/a	n/a	8K	32K	72K	159K	535K	751K	1.15M	771K	271K	n/a
Total Current Liabilities	873K	3M	2.88M	2.71M	3.14M	2.64M	1.86M	2.42M	1.43M	1.97M	783K	636K	1.34M	2.51M	3.21M	1.32M	4.89M	2.62M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.42M
Other Long-Term Liabilities	1.14M	422K	1.56M	14.77M	12.53M	12.42M	11.3M	14.44M	13.95M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.14M	422K	1.57M	15M	22.27M	23.08M	21.87M	39.96M	37.28M	25.89M	28.45M	23.61M	23.51M	24.17M	24.05M	21.6M	21.6M	25.02M
Total Liabilities	2.01M	3.43M	4.45M	19.25M	25.4M	25.72M	23.73M	42.38M	38.72M	27.86M	29.23M	24.24M	24.86M	26.68M	27.26M	22.93M	26.49M	27.64M
Total Debt	28K	37K	47K	275K	286K	296K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	150K	150K	300K	300K	3.72M
Common Stock	219.61M	219.5M	219.5M	219.49M	219.49M	219.43M	218.78M	216.63M	215.83M	158.35M	158.32M	158.29M	158.22M	157.9M	130.65M	130.59M	126.67M	124.55M
Retained Earnings	-242.33M	-240.97M	-239.32M	-210.07M	-170.69M	-165.53M	-159.62M	-65.17M	-57.68M	-56.73M	-55.01M	-47.69M	-44.18M	-41.2M	-38.13M	-26.64M	-25.45M	-23M
Comprehensive Income	n/a	23.98M	23.84M	22.57M	18.86M	19.42M	16.88M	17.48M	20.29M	958K	17.89M	15.18M	13.1M	11.02M	8.94M	958K	958K	1.04M
Shareholders Equity	1.4M	2.51M	4.02M	32M	67.66M	73.31M	76.05M	168.94M	178.43M	120.68M	121.2M	125.79M	127.14M	127.71M	101.45M	104.94M	102.23M	102.65M
Total Investments	n/a	n/a	n/a	6M	3.28M	4.61M	2.89M	4.77M	8.97M	9.02M	9.08M	8.78M	9.04M	9.1M	9.14M	9.9M	10.03M	10.22M